Journal of Nanoparticle Research

, Volume 9, Issue 6, pp 1217–1220 | Cite as

A response to ‘Nanotechnology and the need for risk governance’, O. Renn & M.C. Roco, 2006. J. Nanoparticle Research 8(2): 153–191

  • W. E. Bijker
  • I. D. de Beaufort
  • A. van den Berg
  • P. J. A. Borm
  • W. J. G. Oyen
  • G. T. Robillard
  • H. F. G. van Dijk
Brief Communication

References

  1. Borm P, Klaessig FC, Landry TD, Moudgil B, Pauluhn J, Thomas K, Trottier R, Wood S (2006) Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicol Sci 90(1):23–32CrossRefGoogle Scholar
  2. Health Council of the Netherlands (2006) Health significance of nanotechnologies. The Hague: Health Council of the Netherlands; publication no. 2006/06E; www.healthcouncil.nlGoogle Scholar
  3. Nel A, Xia T, Mädler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–627CrossRefGoogle Scholar
  4. Renn O (2005) White paper on risk governance; towards an integrative approach. White paper no. 1. Geneva: International Risk Governance Council; www.irgc.orgGoogle Scholar
  5. Renn O, Roco MC (2006a) Nanotechnology and the need for risk governance. J Nanopart Res 8(2):153–191CrossRefGoogle Scholar
  6. Renn O, Roco MC (2006b) White paper on nanotechnology risk governance. White paper no. 2. Geneva: International Risk Governance Council; www.irgc.orgGoogle Scholar
  7. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2005) Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. Brussels: European Commission, Health & Consumer Protection Directorate-General, Directorate C—Public Health and Risk AssessmentGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • W. E. Bijker
    • 1
  • I. D. de Beaufort
    • 2
  • A. van den Berg
    • 3
  • P. J. A. Borm
    • 4
    • 5
  • W. J. G. Oyen
    • 6
  • G. T. Robillard
    • 7
  • H. F. G. van Dijk
    • 8
  1. 1.Faculty of Arts and CultureUniversity MaastrichtMaastrichtThe Netherlands
  2. 2.Department of Medical EthicsErasmus Medical Center RotterdamRotterdamThe Netherlands
  3. 3.MESA+Institute, BIOS the Lab-on-a-chip GroupUniversity of TwenteEnschedeThe Netherlands
  4. 4.Center of Expertise in Life SciencesHogeschool ZuydHeerlenThe Netherlands
  5. 5.Institut für Umweltmedizinische ForschungHeinrich-Heine UniversityDusseldorfGermany
  6. 6.Department of Nuclear MedicineRadboud University Nijmegen Medical CentreNijmegenThe Netherlands
  7. 7.BioMaDe TechnologyGroningenThe Netherlands
  8. 8.Health Council of the NetherlandsThe HagueThe Netherlands

Personalised recommendations